Diabetes mellitus and severe mental illness: mechanisms and clinical implications
The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
Hills, A. P., Byrne, N. M., Lindstrom, R., & Hill, J. O. (2013) · Obesity Facts · doi:10.1159/000345030 · Cited by 9,493
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., Meltzer, H. Y., Hsiao, J., Scott Stroup, T., & Lieberman, J. A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.014 · Cited by 1,140
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135
Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088
Correll, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050
De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951
Self-citationThe unhealthy lifestyle of people with schizophrenia
BROWN, S., BIRTWISTLE, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 874
Rates of Adult Schizophrenia Following Prenatal Exposure to the Chinese Famine of 1959-1961
St Clair, D. (2005) · JAMA · doi:10.1001/jama.294.5.557 · Cited by 816
Schizophrenia After Prenatal Famine: Further Evidence
Susser, E. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830010027005 · Cited by 734
Rummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Lobos, C. A., Kissling, W., Davis, J. M., & Leucht, S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.012 · Cited by 675
Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia
Sernyak, M. J., Leslie, D. L., Alarcon, R. D., Losonczy, M. F., & Rosenheck, R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.561 · Cited by 623
Twenty-five year mortality of a community cohort with schizophrenia
Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067512 · Cited by 601
Vitamin D and type 2 diabetes: a systematic review
Mitri, J., Muraru, M. D., & Pittas, A. G. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.118 · Cited by 570
Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study
McCreadie, R. G., & Scottish Schizophrenia Lifestyle Group (2003) · British Journal of Psychiatry · doi:10.1192/03-162 · Cited by 546
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Bak, M., Fransen, A., Janssen, J., van Os, J., & Drukker, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094112 · Cited by 490
Adverse Effects of Atypical Antipsychotics: Differential Risk and Clinical Implications
Haddad, P. M., & Sharma, S. G. (2007) · CNS Drugs · doi:10.2165/00023210-200721110-00004 · Cited by 456
Is birth weight related to later glucose and insulin metabolism?—a systematic review
Newsome, C. A., Shiell, A. W., Fall, C. H. D., Phillips, D. I. W., Shier, R., & Law, C. M. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00871.x · Cited by 455
Vancampfort, D., Vansteelandt, K., Correll, C. U., Mitchell, A. J., De Herdt, A., Sienaert, P., Probst, M., & De Hert, M. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050620 · Cited by 441
Self-citationRoyal Australian And New Zealand College Of Psychiatrists Clinical Practice Guidelines Team For The Treatment Of Schizophrenia And Related Disorders (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01516.x · Cited by 435
Quality of Preventive Medical Care for Patients With Mental Disorders
Druss, B. G., Rosenheck, R. A., Desai, M. M., & Perlin, J. B. (2002) · Medical Care · doi:10.1097/00005650-200202000-00007 · Cited by 376
Mitchell, A. J., Malone, D., & Doebbeling, C. C. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.045732 · Cited by 360
Self-citationBirth weight and the risk of depressive disorder in late life
Thompson, C., Syddall, H., Rodin, I., Osmond, C., & Barker, D. J. P. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.5.450 · Cited by 341
Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine · doi:10.1017/s003329171100105x · Cited by 332
Self-citationMitchell, A. J., Vancampfort, D., De Herdt, A., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs082 · Cited by 327
Self-citationImpaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia
Spelman, L. M., Walsh, P. I., Sharifi, N., Collins, P., & Thakore, J. H. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02092.x · Cited by 318
Vancampfort, D., Correll, C. U., Wampers, M., Sienaert, P., Mitchell, A. J., De Herdt, A., Probst, M., Scheewe, T. W., & De Hert, M. (2014) · Psychological Medicine · doi:10.1017/s0033291713002778 · Cited by 317
Self-citationVancampfort, D., Wampers, M., Mitchell, A. J., Correll, C. U., De Herdt, A., Probst, M., & De Hert, M. (2013) · World Psychiatry · doi:10.1002/wps.20069 · Cited by 317
Self-citationde Vet, E., de Ridder, D. T. D., & de Wit, J. B. F. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00784.x · Cited by 285
Smith, M., Hopkins, D., Peveler, R. C., Holt, R. I. G., Woodward, M., & Ismail, K. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037184 · Cited by 275
Self-citationKvajo, M., McKellar, H., Arguello, P. A., Drew, L. J., Moore, H., MacDermott, A. B., Karayiorgou, M., & Gogos, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802615105 · Cited by 268
Álvarez-Jiménez, M., González-Blanch, C., Crespo-Facorro, B., Hetrick, S., Rodríguez-Sánchez, J. M., Pérez-Iglesias, R., & Vázquez-Barquero, J. L. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00002 · Cited by 264
Seida, J. C., Mitri, J., Colmers, I. N., Majumdar, S. R., Davidson, M. B., Edwards, A. L., Hanley, D. A., Pittas, A. G., Tjosvold, L., & Johnson, J. A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2136 · Cited by 264
Schizophrenia After Prenatal Famine
van Os, J. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180095015 · Cited by 261
Bradley, A. J., & Dinan, T. G. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810385491 · Cited by 256
Jin, H., Meyer, J. M., & Jeste, D. V. (2002) · Annals of Clinical Psychiatry · doi:10.1023/a:1015228112495 · Cited by 249
De Hert, M., Schreurs, V., Sweers, K., Van Eyck, D., Hanssens, L., Šinko, S., Wampers, M., Scheen, A., Peuskens, J., & van Winkel, R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.028 · Cited by 247
Maayan, L., Vakhrusheva, J., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.21 · Cited by 230
Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth
Bobo, W. V., Cooper, W. O., Stein, C. M., Olfson, M., Graham, D., Daugherty, J., Fuchs, D. C., & Ray, W. A. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2053 · Cited by 229
Norris, S. L., Kansagara, D., Bougatsos, C., & Fu, R. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00008 · Cited by 228
Neurological complications of psychiatric drugs: clinical features and management
Haddad, P. M., & Dursun, S. M. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.918 · Cited by 223
Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
Mizuno, Y., Suzuki, T., Nakagawa, A., Yoshida, K., Mimura, M., Fleischhacker, W. W., & Uchida, H. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu030 · Cited by 202
Fineberg, A. M., & Ellman, L. M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.001 · Cited by 201
Menza, M., Vreeland, B., Minsky, S., Gara, M., Radler, D. R., & Sakowitz, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0404 · Cited by 201
Schizophrenia as a GSK-3 dysregulation disorder
Lovestone, S., Killick, R., Di Forti, M., & Murray, R. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.02.002 · Cited by 192
Pringsheim, T., Panagiotopoulos, C., Davidson, J., Ho, J., & The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guideline group (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.9.581 · Cited by 192
Insulin and Insulin-Like Growth Factor-1 Abnormalities in Antipsychotic-Naive Schizophrenia
Venkatasubramanian, G., Chittiprol, S., Neelakantachar, N., Naveen, M. N., Thirthall, J., Gangadhar, B. N., & Shetty, K. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07020233 · Cited by 191
Caemmerer, J., Correll, C. U., & Maayan, L. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.017 · Cited by 182
Chwastiak, L. A., Rosenheck, R. A., & Kazis, L. E. (2011) · Psychosomatics · doi:10.1016/j.psym.2010.12.009 · Cited by 182
Morrato, E. H., Newcomer, J. W., Kamat, S., Baser, O., Harnett, J., & Cuffel, B. (2009) · Diabetes Care · doi:10.2337/dc08-1720 · Cited by 171
De Hert, M., Yu, W., Detraux, J., Sweers, K., van Winkel, R., & Correll, C. U. (2012) · CNS Drugs · doi:10.2165/11634500-000000000-00000 · Cited by 161
Obesity, serious mental illness and antipsychotic drugs
Holt, R. I. G., & Peveler, R. C. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01038.x · Cited by 160
Self-citationValipour, G., Saneei, P., & Esmaillzadeh, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1887 · Cited by 149
Disruption of the Dopamine D2 Receptor Impairs Insulin Secretion and Causes Glucose Intolerance
García-Tornadú, I., Ornstein, A. M., Chamson-Reig, A., Wheeler, M. B., Hill, D. J., Arany, E., Rubinstein, M., & Becu-Villalobos, D. (2010) · Endocrinology · doi:10.1210/en.2009-0996 · Cited by 147
Molecular pathophysiology of metabolic effects of antipsychotic medications
Ballon, J. S., Pajvani, U. B., Freyberg, Z., Leibel, R. L., & Lieberman, J. A. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.07.004 · Cited by 147
Lord, O., Malone, D., & Mitchell, A. J. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.04.004 · Cited by 146
Self-citationA UK Audit of Screening for the Metabolic Side Effects of Antipsychotics in Community Patients
Barnes, T. R. E., Paton, C., Cavanagh, M.-R., Hancock, E., Taylor, D. M., & Health, O. B. O. T. U. P. O. F. M. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm038 · Cited by 145
Diet, diabetes and schizophrenia: Review and hypothesis
Peet, M. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.47.s102 · Cited by 130
Recent advances in the molecular genetics of type 2 diabetes mellitus
Brunetti, A., Chiefari, E., & Foti, D. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i2.128 · Cited by 129
Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes
Lin, P., & Shuldiner, A. R. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.022 · Cited by 125
Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?
Gough, S. C. L., & O’Donovan, M. C. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105058380 · Cited by 121
Diabetes Mellitus and Impaired Glucose Tolerance in Patients with Schizophrenia
Subramaniam, M., Chong, S.-A., & Pek, E. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304800512 · Cited by 114
Ardizzone, T. D., Bradley, R. J., Freeman, A. M., & Dwyer, D. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03026-8 · Cited by 112
Early life predictors of the physiological stress response later in life
Kajantie, E., & Räikkönen, K. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.013 · Cited by 111
Liu, Y., Li, Z., Zhang, M., Deng, Y., Yi, Z., & Shi, T. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-s1-s17 · Cited by 103
Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells
Engl, J., Laimer, M. W., Niederwanger, A., Kranebitter, M., Starzinger, M., Pedrini, M. T., Fleischhacker, W. W., Patsch, J. R., & Ebenbichler, C. F. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001729 · Cited by 101
Starrenburg, F. C. J., & Bogers, J. P. A. M. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.001 · Cited by 100
Huber, T. J., Tettenborn, C., Leifke, E., & Emrich, H. M. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.05.010 · Cited by 99
Diabetes and schizophrenia 2005: are we any closer to understanding the link?
Holt, R. I. G., Bushe, C., & Citrome, L. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105058379 · Cited by 98
Self-citationHaro, J. M., & Salvador‐Carulla, L. (2006) · CNS Drugs · doi:10.2165/00023210-200620040-00003 · Cited by 98
The heart of the matter: cardiometabolic care in youth with psychosis
Curtis, J., Newall, H. D., & Samaras, K. (2012) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00315.x · Cited by 95
van Winkel, R., De Hert, M., Van Eyck, D., Hanssens, L., Hanssens, L., Wampers, M., Scheen, A., & Peuskens, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1002 · Cited by 92
Saddichha, S., Manjunatha, N., Ameen, S., & Akhtar, S. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01158.x · Cited by 88
Bhavsar, V., Boydell, J. E., Murray, R. M., & Power, P. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.014 · Cited by 87
Parental history of Type 2 diabetes in patients with nonaffective psychosis
Fernández-Egea, E., Miller, B., Bernardo, M., Donner, T. W., & Kirkpatrick, B. W. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.002 · Cited by 86
Dietary improvement in people with schizophrenia: Randomised controlled trial
McCreadie, R. G., Kelly, C., Connolly, M., Williams, S., Baxter, G., Lean, M., & Paterson, J. R. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.4.346 · Cited by 82
Receipt of Diabetes Services by Insured Adults With and Without Claims for Mental Disorders
Jones, L. E., Clarke, W., & Carney, C. P. (2004) · Medical Care · doi:10.1097/00005650-200412000-00003 · Cited by 79
Colman, I., Ataullahjan, A., Naicker, K., & Lieshout, R. J. V. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700705 · Cited by 76
Antipsychotics and Diabetes: An Age-Related Association
Hammerman, A., Dreiher, J., Klang, S. H., Munitz, H., Cohen, A. D., & Goldfracht, M. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l015 · Cited by 75
Association between antipsychotic drugs and diabetes
Holt, R. I. G., & Peveler, R. C. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00495.x · Cited by 73
Self-citationJoffe, G., Takala, P., Tchoukhine, E., Hakko, H., Raidma, M., Putkonen, H., Eronen, M., & Rasanen, P. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0503 · Cited by 71
Antipsychotic drugs and diabetes—an application of the Austin Bradford Hill criteria
Holt, R. I. G., & Peveler, R. (2006) · Diabetologia · doi:10.1007/s00125-006-0279-3 · Cited by 70
Self-citationRibe, A. R., Laursen, T. M., Sandbaek, A., Charles, M., Nordentoft, M., & Vestergaard, M. (2014) · Psychological Medicine · doi:10.1017/s0033291714000634 · Cited by 69
Graham, K. A., Cho, H., Brownley, K. A., & Harp, J. B. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.476 · Cited by 65
Risk of Acute Complications of Diabetes Among People With Schizophrenia in Ontario, Canada
Becker, T., & Hux, J. (2011) · Diabetes Care · doi:10.2337/dc10-1139 · Cited by 65
Risk of Treatment-Emergent Diabetes Mellitus in Patients Receiving Antipsychotics
Citrome, L. L., Holt, R. I., Zachry, W. M., Clewell, J. D., Orth, P. A., Karagianis, J. L., & Hoffmann, V. P. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k141 · Cited by 64
Self-citationChiba, M., Suzuki, S., Hinokio, Y., Hirai, M., Sato, Y., Tashiro, A., Utsumi, A., Awata, T., Hongo, M., & Toyota, T. (2000) · Metabolism · doi:10.1053/meta.2000.8611 · Cited by 64
Chen, C., Chen, Y., & Huang, Y. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2008.01886.x · Cited by 62
Taylor, D., Young, C., Mohamed, R., Paton, C., & Walwyn, R. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105049039 · Cited by 59
Jenkinson, C., Hanson, R. L., Cray, K., Wiedrich, C., Knowler, W. C., Bogardus, C., & Baier, L. J. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801381 · Cited by 56
The increase in risk of diabetes mellitus from exposure to second-generation antipsychotic agents
Citrome, L. L. (2004) · Drugs of Today · doi:10.1358/dot.2004.40.5.850492 · Cited by 56
Hardy, S., Hinks, P., & Gray, R. J. (2013) · Journal of Mental Health · doi:10.3109/09638237.2012.759194 · Cited by 51
McIntyre, R. S., Alsuwaidan, M., Goldstein, B. I., Taylor, V. H., Schaffer, A., Beaulieu, S., & Kemp, D. E. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400108 · Cited by 45
Fetal growth restriction and the development of major depression
Vasiliadis, H., Gilman, S. E., & Buka, S. L. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01168.x · Cited by 45
Genetics of Antipsychotic-Induced Weight Gain: Update and Current Perspectives
Kao, A. C.-C., & Müller, D. J. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.207 · Cited by 44
Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.
Bushe, C., & Leonard, B. E. (2007) · PubMed · Cited by 43
Voruganti, L. P., Punthakee, Z., VANLIESHOUT, R., MacCrimmon, D. J., PARKER, G., AWAD, A., & Gerstein, H. C. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.07.016 · Cited by 39
Blood Glucose and Schizophrenia: A Systematic Review of Prospective Randomized Clinical Trials
Bushe, C. J., & Leonard, B. E. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1107 · Cited by 38
Atypical Antipsychotics in Psychiatric Practice: Practical Implications for Clinical Monitoring
Poulin, M.-J., Cortese, L., Williams, R. L., Wine, N., & McIntyre, R. S. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000909 · Cited by 34
Taylor, J., Cottrell, C., Chatterton, H., Hill, J., Hughes, R., Wohlgemuth, C., & Holt, R. I. G. (2013) · Diabetic Medicine · doi:10.1111/dme.12027 · Cited by 33
Self-citationMitchell, A. J., & Hardy, S. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200514 · Cited by 33
Self-citationIntentional Weight Loss in Overweight and Obese Patients With Severe Mental Illness
Holt, R. I. G., Pendlebury, J., Wildgust, H. J., & Bushe, C. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05627gre · Cited by 32
Self-citationScreening for Metabolic Syndrome in Older Patients with Severe Mental Illness
Konz, H., Meesters, P. D., Paans, N. P. G., Grootheest, D. S. V., Comijs, H. C., Stek, M. L., & Dols, A. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.01.011 · Cited by 26
Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
Manu, P., Correll, C. U., Wampers, M., van Winkel, R., Yu, W., Shiffeldrim, D., Kane, J. M., & Binder, M. D. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.11.016 · Cited by 25
Schizophrenia: a multisystem disease?
Mitchell, A. J., & Dinan, T. G. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382059 · Cited by 24
Self-citationGorczynski, P. F., Patel, H., & Ganguli, R. (2014) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.gopa.013114 · Cited by 21
Diabetes Risk Potentially Underestimated in Youth and Children Receiving Antipsychotics
Samaras, K., Correll, C. U., Mitchell, A. J., & Binder, M. D. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4030 · Cited by 19
Self-citationLarsen, J. R., Vedtofte, L., Holst, J. J., Oturai, P., Kjær, A., Corell, C. U., Vilsbøll, T., & Fink-Jensen, A. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004227 · Cited by 19
Quetiapine Treatment in Youth Is Associated With Decreased Insulin Secretion
Ngai, Y. F., Sabatini, P. V., Nguyen, D., Davidson, J., Chanoine, J., Devlin, A. M., Lynn, F. C., & Panagiotopoulos, C. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000118 · Cited by 18
Undoing Descartes: integrating diabetes care for those with mental illness
Holt, R. (2011) · Practical Diabetes · doi:10.1002/pdi.1613 · Cited by 17
Self-citationHunter, E. M. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416670523 · Cited by 16
Immunological characteristics of diabetes in schizophrenia
Cohen, D., Batstra, M. R., & Wied, C. C. G. (2005) · Diabetologia · doi:10.1007/s00125-005-1879-z · Cited by 15
The effects of antipsychotic switching on diabetes in chronic schizophrenia
Arnoldy, R., Curtis, J., & Samaras, K. (2013) · Diabetic Medicine · doi:10.1111/dme.12359 · Cited by 15
Cited by
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
“of death in people with SMI are physical diseases (10).”
BackgroundBarnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Cooper, S. J., Reynolds, G. P., order):, W. E. C.-A. (. A., Barnes, T., England, E., Haddad, P., Heald, A., Holt, R., Lingford-Hughes, A., Osborn, D., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645254 · Cited by 292
“These metabolic disturbances are multifactorial in origin (Holt and Mitchell, 2015; Manu et al., 2015).”
BackgroundSelf-citationHenderson, D. C., Vincenzi, B., Andrea, N. V., Ulloa, M., & Copeland, P. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00115-7 · Cited by 288
Association between antipsychotic medication use and diabetes
Holt, R. I. G. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1220-8 · Cited by 162
Self-citation
Metadata
- Authors
- Holt, R. I. G., & Mitchell, A. J.
- Venue
- Nature Reviews Endocrinology
- Published
- 2014-12-02
- Volume
- 11
- Issue
- 2
- Pages
- 79-89
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2041688900
- Cited by
- 179
- References
- 125
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.